Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
Authors
Keywords
Coronary microcirculation, Diabetes Mellitus, Type 2 diabetes, Glucagon-like peptide-1, Coronary flow reserve, Microvascular dysfunction, Endothelial function, Liraglutide, Intervention study, Cross-over design
Journal
Cardiovascular Diabetology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-04-21
DOI
10.1186/s12933-015-0206-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Do incretins improve endothelial function?
- (2014) Jun-ichi Oyama et al. Cardiovascular Diabetology
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
- (2014) Manfredi Rizzo et al. Cardiovascular Diabetology
- Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes
- (2014) Venkatesh L. Murthy et al. CIRCULATION
- GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans
- (2014) Sharmila C. Subaran et al. CLINICAL SCIENCE
- Test–retest reliability of peripheral arterial tonometry in the metabolic syndrome
- (2014) Katherine A Sauder et al. Diabetes & Vascular Disease Research
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Prognostic Meaning of Coronary Microvascular Disease in Type 2 Diabetes Mellitus: A Transthoracic Doppler Echocardiographic Study
- (2014) Lauro Cortigiani et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
- (2013) Steven P. Marso et al. AMERICAN HEART JOURNAL
- Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
- (2013) Ting C Zhao Cardiovascular Diabetology
- Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease
- (2013) Takayuki Kawata et al. Cardiovascular Diabetology
- Glucagon-Like Peptide-1 Protects Against Cardiac Microvascular Injury in Diabetes via a cAMP/PKA/Rho-Dependent Mechanism
- (2013) D. Wang et al. DIABETES
- Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients
- (2013) N. D. Hopkins et al. DIABETES OBESITY & METABOLISM
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients
- (2013) Makoto Ayaori et al. Journal of the American Heart Association
- Racial Differences in Arterial Stiffness and Microcirculatory Function Between Black and White Americans
- (2013) Alanna A. Morris et al. Journal of the American Heart Association
- Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects
- (2012) Betsy B. Dokken et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
- (2012) Aaron S Kelly et al. Cardiovascular Diabetology
- GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
- (2012) Dhanwantee Mundil et al. Diabetes & Vascular Disease Research
- Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: Results from an observational research
- (2012) Concetta Irace et al. Diabetes & Vascular Disease Research
- Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function
- (2012) T. Forst et al. DIABETIC MEDICINE
- Methods to investigate coronary microvascular function in clinical practice
- (2012) Gaetano A. Lanza et al. Journal of Cardiovascular Medicine
- Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes
- (2012) M. Gejl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Coronary Flow Reserve During Dipyridamole Stress Echocardiography Predicts Mortality
- (2012) Lauro Cortigiani et al. JACC-Cardiovascular Imaging
- Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease
- (2011) Philip A Read et al. HEART
- Factors predicting coronary flow reserve impairment in patients evaluated for chest pain: An ultrasound study
- (2010) Bernardino Tuccillo et al. Journal of Cardiovascular Medicine
- Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia
- (2010) Carl J. Pepine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Glucagon-like peptide-1 (GLP-1) attenuates post-resuscitation myocardial microcirculatory dysfunction
- (2010) Betsy B. Dokken et al. RESUSCITATION
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study
- (2008) Naomi M. Hamburg et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now